B2TK87 AF NFT

D-ribose pyranase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicdabf3qfjkauc5tmf3ok4wzo227srtgzqpkl57lzh5zrlt4ht3ua/metadata.json
IPFS of structure file: 
bafybeibgwcqwzk5yzdqq3whxekuafc6wwbeevldetyxnev4hi6pxpkgega/AF-B2TK87-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x93c9c10cD9Ce1353A32B4e012FD69d78688DF18A
First NFT owner address (bech32): 
genesis1j0yuzrxeecf48getfcqjl45a0p5gmuv2cyrgfa
Current NFT ID #335094 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
335094
Accession (UniProt):
B2TK87
Name::
D-ribose pyranase
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Eklund 17B / Type B)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2TK87 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2TK87|RBSD_CLOBB D-ribose pyranase OS=Clostridium botulinum (strain Eklund 17B / Type B) OX=935198 GN=rbsD PE=3 SV=1 MRKTALLNSDLSSVISKMGHTDMIAIGDCGLPIPAESERIDLALIKGIPTFMQTLKTTLLELQIEEVILAKETEAVSPDLYEEIKEVIGDVKITFITHEELKTTLKSCKAVVRTGEQTPYANIILKSGVVF